Human Cathelicidin LL-37 Resistance and Increased Daptomycin MIC in Methicillin-Resistant Staphylococcus aureus Strain USA600 (ST45) Are Associated with Increased Mortality in a Hospital Setting

Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?

(2013) S. J. van Hal et al.   CLINICAL INFECTIOUS DISEASES

Readmission Following Hospitalization for Pneumonia: The Impact of Pneumonia Type and Its Implication for Hospitals

(2013) Andrew F. Shorr et al.   CLINICAL INFECTIOUS DISEASES

Emergence of Daptomycin Resistance in Daptomycin-Naïve Rabbits with Methicillin-Resistant Staphylococcus aureus Prosthetic Joint Infection Is Associated with Resistance to Host Defense Cationic Peptides and mprF Polymorphisms

(2013) Nagendra N. Mishra et al.   PLoS One

Molecular Epidemiology of Community-Associated Methicillin-resistant Staphylococcus aureus in the genomic era: a Cross-Sectional Study

(2013) Mattia Prosperi et al.   Scientific Reports

A comprehensive summary of LL-37, the factotum human cathelicidin peptide

(2012) Dieter Vandamme et al.   CELLULAR IMMUNOLOGY

Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients

(2012) N. N. Mishra et al.   JOURNAL OF INFECTIOUS DISEASES

Elevated Serum Interleukin-10 at Time of Hospital Admission Is Predictive of Mortality in Patients With Staphylococcus aureus Bacteremia

(2012) Warren E. Rose et al.   JOURNAL OF INFECTIOUS DISEASES

Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool

(2011) Carol L. Moore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2011) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

(2011) A. Dhand et al.   CLINICAL INFECTIOUS DISEASES

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

(2011) Natasha E. Holmes et al.   JOURNAL OF INFECTIOUS DISEASES

USA600 (ST45) Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Urban Detroit

(2010) C. L. Moore et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

(2009) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Low Plasma Level of Cathelicidin Antimicrobial Peptide (hCAP18) Predicts Increased Infectious Disease Mortality in Patients Undergoing Hemodialysis

(2009) Adrian F. Gombart et al.   CLINICAL INFECTIOUS DISEASES

Factors Influencing Time to Vancomycin‐Induced Clearance of Nonendocarditis Methicillin‐ResistantStaphylococcus aureusBacteremia: Role of Platelet Microbicidal Protein Killing andagrGenotypes

(2009) Pamela A. Moise et al.   JOURNAL OF INFECTIOUS DISEASES

The roles of cathelicidin LL-37 in immune defences and novel clinical applications

(2008) Anastasia Nijnik et al.   CURRENT OPINION IN HEMATOLOGY